$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

마이크로어레이 분석기법의 임상적용에 관한 연구
Medical Implementation of Microarray Technology 원문보기

Korean journal of clinical laboratory science : KJCLS = 대한임상검사과학회지, v.52 no.4, 2020년, pp.310 - 316  

강지언 (나사렛대학교 임상병리학과)

초록
AI-Helper 아이콘AI-Helper

마이크로어레이 진단 기법의 발달은 세포유전학적 관점에서, 다양한 종류의 유전학적 질병과 관련하여 새로운 정보를 제공하고, 질병에 대한 기본적인 통찰력을 제공하는데 매우 중요한 역할을 제공하고 있다. 그동안 많은 연구들에서, 마이크로어레이 기술을 활용한 인간 게놈의 유동성과 다양성을 입증해 주었으며, 게놈의 취약성을 식별하기 위한 보다 정확한 진단기법과 적절한 임상 관리 방법을 효율적으로 제공해 왔다. 앞으로 다양한 유전과 관련된 질병에 기존 세포유전학적 방법을 자동화된 마이크로어레이 방법으로 전환한다면, 보다 효율적인 방법으로 질병을 진단하고, 정확성을 향상시키며, 유전자 배열의 암호화 및 복잡한 특성을 밝히는데 매우 중요한 역할을 할 것으로 생각된다. 또한 이 분석 기법을 활용하여 게놈과 인간의 건강, 질병과의 관계를 분석하여 다양한 정보를 미리 제공하여 질병을 예방하고, 질병의 진단 및 치료에도 도움이 될 수 있는 새로운 혁명을 일으킬 수 있을 것으로 기대된다.

Abstract AI-Helper 아이콘AI-Helper

Microarray technology represents a critical new advance in molecular cytogenetics. The development of this approach has provided fundamental insights into the molecular pathogenesis in clinical cytogenetics and has provided a clue to many unidentified or unexplained diseases. The approach allows a c...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

문제 정의

  • Additionally, his technologies are revealing the tremendous fluidity and complexity of the human genome and transforming the field of cytogenetics [4]. In this article, we review the overview of methods of cytogenetic and highlight a potential utility of array based technologies in the identification of cytogenetic abnormalities and the implications for clinical applications (Figure 2).
본문요약 정보가 도움이 되었나요?

참고문헌 (40)

  1. Arenillas L, Mallo M, Ramos F, Guinta K, Barragan E, Lumbreras E, et al. Single nucleotide polymorphism array karyotyping: a diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing. Genes Chromosomes Cancer. 2013;52:1167-1177. https://doi.org/10.1002/gcc.22112 

  2. Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet. 2005;6:782-792. https://doi.org/10.1038/nrg1692 

  3. Darilek S, Ward P, Pursley A, Plunkett K, Furman P, Magoulas P, et al. Pre and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives. Genet Med. 2008;10:13-18. https://doi.org/10.1097/GIM.0b013e31815f1ddb 

  4. Li MM, Andersson HC. Clinical application of microarray-based molecular cytogenetics: an emerging new era of genomic medicine. J Pediatr. 2009;155:311-317. https://doi.org/10.1016/j.jpeds.2009.04.001 

  5. Kang JU, Koo SH. Evolving applications of microarray technology in postnatal diagnosis (review). Int J Mol Med. 2012:30:223-228. https://doi.org/10.3892/ijmm.2012.988 

  6. Savl H, Uzulmez N, Ilkay Z, Yavuz D, Sunnetci D, Hachanifioglu A, et al. High throughput FISH analysis: a new, sensitive option for evaluation of hematological malignancies. Turk J Haematol. 2013;30:122-128. https://doi.org/10.4274/Tjh.2012.0033 

  7. Kang JU. Overview of cytogenetic technologies. Korean J Clin Lab Sci. 2018;50:375-381. https://doi.org/10.15324/kjcls.2018.50.4.375 

  8. Varella-Garcia M. Molecular cytogenetics in solid tumors: laboratorial tool for diagnosis, prognosis, and therapy. Oncologist. 2003;8:45-58. https://doi.org/10.1634/theoncologist.8-1-45 

  9. Kang JU, Koo SH. Clinical implementation of chromosomal microarray technology in prenatal diagnosis. Mol Med Rep. 2012:6:1219-1222. https://doi.org/10.3892/mmr.2012.1116 

  10. Dave BJ, Sanger WG. Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances. Semin Pediatr Neurol. 2007;14:2-6. https://doi.org/10.1016/j.spen.2006.11.003 

  11. Li M, Pinkel D. Clinical cytogenetics and molecular cytogenetics. J Zhejiang Univ Sci B. 2006;7:162-163. https://doi.org/10.1631/jzus.2006.B0162 

  12. Shaffer LG, Bejjani BA. Medical applications of array CGH and the transformation of clinical cytogenetics. Cytogenet Genome Res. 2006;115:303-309. https://doi.org/10.1159/000095928 

  13. Raynaud CM, Sabatier L, Philipot O, Olaussen KA, Soria JC. Raynaud CM, et al. Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Crit Rev Oncol Hematol. 2008;66:99-117. https://doi.org/10.1016/j.critrevonc.2007.11.006 

  14. Oostlander AE, Meijer GA, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet. 2004;66:488-495. https://doi.org/10.1111/j.1399-0004.2004.00322.x 

  15. Bejjani BA, Theisen AP, Ballif BC, Shaffer LG. Array-based comparative genomic hybridization in clinical diagnosis. Expert Rev Mol Diagn. 2005;5:421-429. https://doi.org/10.1586/14737159.5.3.421 

  16. Bejjani BA, Shaffer LG. Clinical utility of contemporary molecular cytogenetics. Annu Rev Genomics Hum Genet. 2008;9:71-86. https://doi.org/10.1146/annurev.genom.9.081307.164207 

  17. Morrow EM. Genomic copy number variation in disorders of cognitive development. J Am Acad Child Adolesc Psychiatry. 2010;49:1091-1104. https://doi.org/10.1016/j.jaac.2010. 08.009 

  18. Marshall CR, Scherer SW. Detection and characterization of copy number variation in autism spectrum disorder. Methods Mol Biol. 2012;838:115-135. https://doi.org/10.1007/978-1-61779-507-7_5 

  19. Koolen DA, Pfundt R, de Leeuw N, Hehir-Kwa JY, Nillesen WM, Neefs I, et al. Genomic microarrays in mental retardation: a practical workflow for diagnostic applications. Hum Mutat. 2009;30:283-292. https://doi.org/10.1002/humu.20883 

  20. Vasudevan P, Suri M. A clinical approach to developmental delay and intellectual disability. Clin Med (Lond). 2017;17:558-561. https://doi.org/10.7861/clinmedicine.17-6-558 

  21. Shevell M, Ashwal S, Donley D, Flint J, Gingold M, Hirtz D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003;60:367-380. https://doi.org/10.1212/01.wnl.0000031431.81555.16 

  22. Ravnan JB, Tepperberg JH, Papenhausen P, Lamb AN, Hedrick J, Eash D, et al. Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet. 2006;43:478-489. https://doi.org/10.1136/jmg.2005.036350 

  23. Lu XY, Phung MT, Shaw CA, Pham K, Neil SE, Patel A, et al. Genomic imbalances in neonates with birth defects: high detection rates by using chromosomal microarray analysis. Pediatrics. 2008;122:1310-1308. https://doi.org/10.1542/peds.2008-0297 

  24. J Dave, WG Sanger. Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances. Semin Pediatr Neurol. 2007;14:2-6. https://doi.org/10.1016/j.spen.2006.11.003 

  25. Lichtenbelt KD, Knoers NV, Schuring-Blom GH. From karyotyping to array-CGH in prenatal diagnosis. Cytogenet Genome Res. 2011;135:241-250. https://doi.org/10.1159/000334065 

  26. Moeschler JB, Shevell M; Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:e903-918. https://doi.org/10.1542/peds.2014-1839 

  27. Fan YS, Jayakar P, Zhu H, Barbouth D, Sacharow S, Morales A, et al. Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization. Hum Mutat. 2007; 28:1124-1132. https://doi.org/10.1002/humu.20581 

  28. Jaillard S, Drunat S, Bendavid C, Aboura A, Etcheverry A, Journel H, et al. Identification of gene copy number variations in patients with mental retardation using array-CGH: novel syndromes in a large French series. Eur J Med Genet. 2010;53:66-75. https://doi.org/10.1016/j.ejmg.2009.10.002 

  29. Edelmann L, Hirschhorn K. Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann N Y Acad Sci. 2009;1151:157-166. https://doi.org/10.1111/j.1749-6632.2008.03610.x 

  30. Gonzalez G, Raggio V, Boidi M, Tapie A, Roche L. Advances in the identification of the aetiology of mental retardation. Rev Neurol. 2013;57:S75-83. https://doi.org/10.33588/rn.57S01.2013242 

  31. Batzir NA, Shohat M, Maya I. Chromosomal microarray analysis (CMA) a clinical diagnostic tool in the prenatal and postnatal settings. Pediatr Endocrinol Rev. 2015;13:448-454. 

  32. Lu X, Shaw CA, Patel A, Li J, Cooper ML, Wells WR, et al. Clinical implementation of chromosomal microarray analysis: summary of 2513 postnatal cases. PLoS One. 2007;28;2:e327. https://doi.org/10.1371/journal.pone.0000327 

  33. Peters GB, Pertile MD. Chromosome microarrays in diagnostic testing: interpreting the genomic data. Methods Mol Biol. 2014;1168:117-155. https://doi.org/10.1007/978-1-4939-0847-9_8 

  34. Bui TH, Vetro A, Zuffardi O, Shaffer LG. Current controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era? Prenat Diagn. 2011;31:235-243. https://doi.org/10.1002/pd.2722 

  35. de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM, et al. Diagnostic genome profiling in mental retardation. Am J Hum Genet. 2005;77:606-616. https://doi.org/10.1086/491719 

  36. Society for Maternal-Fetal Medicine (SMFM), Dugoff. Electronic address: pubs@smfm.org, Dugoff L, Norton ME, Kuller JA. The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016;215:B2-9. https://doi.org/10.1016/j.ajog.2016.07.016 

  37. Wang Y, Cao L, Liang D, Meng L, Wu Y, Qiao F, et al. Prenatal chromosomal microarray analysis in fetuses with congenital heart disease: a prospective cohort study. Am J Obstet Gynecol. 2018;218:244.e1-244.e17. https://doi.org/10.1016/j.ajog.2017.10.225 

  38. Evangelidou P, Sismani C, Ioannides M, Christodoulou C, Koumbaris G, Kallikas I, et al. Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations. Mol Cytogenet. 2010;26;3:24. https://doi.org/10.1186/1755-8166-3-24 

  39. Liu J, Bernier F, Lauzon J, Lowry RB, Chernos J. Liu J, et al. Application of microarray-based comparative genomic hybridization in prenatal and postnatal settings: three case reports. Genet Res Int. 2011;2011:976398. https://doi.org/10.4061/2011/976398 

  40. Best S, Wou K, Vora N, Van der Veyver IB, Wapner R, Chitty LS. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagn. 2018;38:10-19. https://doi.org/10.1002/pd.5102 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로